HCW Biologics (HCWB) Consolidated Net Income (2021 - 2025)
Historic Consolidated Net Income for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to -$3.4 million.
- HCW Biologics' Consolidated Net Income rose 1263.29% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.7 million, marking a year-over-year increase of 6599.53%. This contributed to the annual value of -$30.1 million for FY2024, which is 1580.99% down from last year.
- According to the latest figures from Q3 2025, HCW Biologics' Consolidated Net Income is -$3.4 million, which was up 1263.29% from -$3.7 million recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Consolidated Net Income registered a high of -$1.9 million during Q1 2022, and its lowest value of -$15.3 million during Q2 2024.
- Its 5-year average for Consolidated Net Income is -$4.9 million, with a median of -$3.9 million in 2024.
- In the last 5 years, HCW Biologics' Consolidated Net Income tumbled by 23207.9% in 2024 and then surged by 7585.73% in 2025.
- Quarter analysis of 5 years shows HCW Biologics' Consolidated Net Income stood at -$3.1 million in 2021, then tumbled by 85.12% to -$5.8 million in 2022, then crashed by 86.87% to -$10.8 million in 2023, then soared by 68.35% to -$3.4 million in 2024, then decreased by 0.33% to -$3.4 million in 2025.
- Its Consolidated Net Income was -$3.4 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$2.2 million in Q1 2025.